IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Crispr Therapeutics AG (CRSP)

CUSIP: H17182908 | Healthcare · Biotechnology | Mid Cap | 16 institutional holders

Quarters

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2026

AlphaCore Capital LLC167
0.0% of portfolio›$82.0K
StyleTurnoverLocationFiled
AlphaCore Capital LLC
167$82.0K0.0%ETFLowLa Jolla, CA2026-11-04